lobbying_activities: 505063

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
505063	340c9e77-b702-4fd3-9a54-3d82de3875b3	MM	CAPITOL SOLUTIONS	47108	AMGEN USA	2007	mid_year	FOO	The FDA’s issuance of a black box warning for erythropoietin stimulating agents H.R. 2900 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the post-market authorities of the Food and Drug Administration with respect to the safety of drugs	HOUSE OF REPRESENTATIVES,SENATE	100000		0	0	2007-07-23T15:14:37-04:00